Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis
Sponsor: Peking University First Hospital
Summary
This is a multicenter randomized, placebo-controlled trial of Vitamin D supplementation in patients on peritoneal dialysis to determine whether oral administration of vitamin D3 after curing an episode of peritonitis could reduce the risk of subsequent peritoneal dialysis-related peritonitis.
Official title: The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis, a Multicenter Randomized Controlled Trial
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
176
Start Date
2023-06-15
Completion Date
2026-05-31
Last Updated
2024-08-06
Healthy Volunteers
No
Interventions
Cholecalciferol
Patients in the intervention group will receive oral cholecalciferol 4000U per day.
Placebo
Patients in the control group will receive placebo 2 capsules per day.
Locations (1)
Peking University First Hospital
Beijing, Beijing Municipality, China